Stock Price Quote

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE3139.40-5.95 (-0.19 %)
PREV CLOSE ( ) 3145.35
OPEN PRICE ( ) 3191.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 983
TODAY'S LOW / HIGH ( )3125.00 3191.25
52 WK LOW / HIGH ( )3000 4900
NSE3139.90-8.05 (-0.26 %)
PREV CLOSE( ) 3147.95
OPEN PRICE ( ) 3165.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10140
TODAY'S LOW / HIGH( ) 3120.15 3165.90
52 WK LOW / HIGH ( )3005 4910
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1979
Management Info
Narayan K Seshadri - Chairman Gagandeep Singh Bedi - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone 080 6774 8000

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com/india

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX

NEWS

10Aug Appointment Of Ms. Revathy Ashok As I
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
10Aug Announcement under Regulation 30 (LOD
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
09Aug Board declares Interim Dividend
AstraZeneca Pharma India Ltd has informed BSE that the Board of Director..
02Aug Board Meeting Intimation for Meeting
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Bo..
28May AstraZeneca Pharma, Abbott Healthcare
AstraZeneca Pharma and Abbott Healthcare have mutually terminated the di..

Financials

in Millions
QTR Jun 21 ANNUAL 21
Net Profit102.42933.039999999999
Gross Profit 135.03 1270.94
Operating Profit 185.31483.13
Net Sales 1754.028135.63

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Hester Biosciences (BSE)
peergroup  2524.10 (1.22%)
M.Cap ( in Cr)2147.22
Kwality Pharma (BSE)
peergroup  625.00 (2.45%)
M.Cap ( in Cr)648.51
JB Chem & Pharma (BSE)
peergroup  1739.10 (0.85%)
M.Cap ( in Cr)13440.13
Aarti Drugs (BSE)
peergroup  631.60 (2.35%)
M.Cap ( in Cr)5848.62
Medico Remedies (BSE)
peergroup  245.00 (4.26%)
M.Cap ( in Cr)101.66

Shareholding Pattern

PROMOTERS 75%
NON-INSTITUTION 21.56%
MUTUAL FUNDS/UTI 0.94%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Astrazeneca Pharma India Ltd.

Astrazeneca Pharma India Ltd. was incorporated in the year 1979. Its today's share price is 3139.4. Its current market capitalisation stands at Rs 7848.5 Cr. In the latest quarter, company has reported Gross Sales of Rs. 8135.6 Cr and Total Income of Rs.8264 Cr. The company's management includes Pratap Rudra, Rajesh Marwaha, Gagandeep Singh Bedi, Weiying Sarah Wang, Ankush Nandra, Kimsuka Narsimhan, Revathy Ashok, Narayan K Seshadri.

It is listed on the BSE with a BSE Code of 506820 , NSE with an NSE Symbol of ASTRAZEN and ISIN of INE203A01020. It's Registered office is at Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring RoadBengaluru-560045, Karnataka. Their Registrars are ACC Ltd. It's auditors are AF Ferguson & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, Price Waterhouse & Co, Price Waterhouse & Co Chartered Accountants LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)